Sorafenib analogues exhibit dual Colistin-potentiating and anti-MRSA activity

Amy Sorge, Andrew Stiles, Ansley M. Nemeth, Ian O'Keefe, Roberta J. Melander, Yohei Doi, Robert K. Ernst, Christian Melander

Open source

DOI
10.1039/d6md00388e
Published
2026
Container
RSC Medicinal Chemistry
Publisher
Royal Society of Chemistry (RSC)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1039/d6md00388e,
  title = {Sorafenib analogues exhibit dual Colistin-potentiating and anti-MRSA activity},
  author = {Amy Sorge and Andrew Stiles and Ansley M. Nemeth and Ian O'Keefe and Roberta J. Melander and Yohei Doi and Robert K. Ernst and Christian Melander},
  year = {2026},
  journal = {RSC Medicinal Chemistry},
  doi = {10.1039/d6md00388e},
  url = {https://doi.org/10.1039/d6md00388e}
}

RIS

TY  - JOUR
TI  - Sorafenib analogues exhibit dual Colistin-potentiating and anti-MRSA activity
AU  - Amy Sorge
AU  - Andrew Stiles
AU  - Ansley M. Nemeth
AU  - Ian O'Keefe
AU  - Roberta J. Melander
AU  - Yohei Doi
AU  - Robert K. Ernst
AU  - Christian Melander
PY  - 2026
JO  - RSC Medicinal Chemistry
DO  - 10.1039/d6md00388e
UR  - https://doi.org/10.1039/d6md00388e
ER  - 

APA

Sorge, A., Stiles, A., Nemeth, A. M., O'Keefe, I., Melander, R. J., Doi, Y., Ernst, R. K., & Melander, C. (2026). Sorafenib analogues exhibit dual Colistin-potentiating and anti-MRSA activity. RSC Medicinal Chemistry. https://doi.org/10.1039/d6md00388e

Source records